Dolphins living along Florida’s coast appear to be affected by the same types of environmental factors that are being ...

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, today announced the publication of two studies demonstrating the Afirma GRID (Genomic Resource for Intelligent Discovery) research ...

Genes on the sex chromosomes would be expected to show different activity between men (with an X chromosome and a Y ...

Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Veracyte Inc (VCYT) reports a 14% revenue increase and record EBITDA margin, while navigating competitive pressures and ...

Onions with glossy leaves possess an unexpected advantage: natural resistance to thrips, one of the crop’s most damaging pests. Researchers identified a premature stop codon mutation in the ...

Cash and Cash Equivalents: As of September 30, 2025, Kymera had $978.7 million in cash, cash equivalents and investments. Kymera expects that its cash balance will provide the Company with a cash ...

Researchers found that hydrogen sulfide, the gas behind the smell of rotten eggs, killed fungal pathogens within hours in lab ...

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced financial results for the third quarter ended September 30, 2025.

The U.S. FDA’s complete response letter (CRL) for Biohaven Ltd.’s lead asset, troriluzole, to treat spinocerebellar ataxia has prompted a wave of downstream changes at the company. There will be a ...